PHARMATEK · Gastroentérologie
Calculateur du score de Rockall clinique (préendoscopique) original
Calculer le total entier brut du score de Rockall clinique/préendoscopique original et les points de ses trois composantes à partir d’une présentation initiale unique, complète et vérifiée.
Partager l’outil sans les valeurs saisies.
La révision clinique doit être complétée.
Cet outil fait partie de la bibliothèque PharmaTek. Son calcul reste indisponible au public jusqu’à la validation de sa formule, de ses limites et de ses sources.
Explorer les outils accessiblesSources, population et validation
- État
- clinical-review-pending
- Version de la méthode
- Rockall et al. 1996 original clinical/pre-endoscopy Rockall arithmetic v1 (raw integer 0–7): completed age <60 years = 0 points, 60–79 = 1, and >=80 = 2. Presentation shock is assigned from systolic blood pressure and heart rate: systolic blood pressure >=100 mmHg with heart rate <100 beats/min = no shock and 0 points; systolic blood pressure >=100 mmHg with heart rate >=100 beats/min = tachycardia and 1 point; systolic blood pressure <100 mmHg = hypotension and 2 points regardless of heart rate. One clinician-assessed source comorbidity category is required: none = 0; cardiac failure, ischemic heart disease, or another major comorbidity = 2; renal failure, liver failure, or disseminated malignancy = 3. The raw total is the unrounded sum of these three complete component assignments. The distinct complete/post-endoscopy Rockall model, including endoscopic diagnosis and stigmata, is excluded; no partial score, threshold, category, probability, prognosis, disposition, endoscopy timing, management, or treatment logic is supplied.
- Population
- People older than 16 years with independently established suspected acute upper-gastrointestinal hemorrhage at one initial pre-endoscopy presentation for whom applicability of the original UK multicentre population-based setting is independently established. The score was derived from 4,185 unselected cases identified over four months in 1993 and prospectively validated in 1,625 cases identified over three months in 1994. Completed age, systolic blood pressure, heart rate, and one explicit clinician-assessed source comorbidity category must be complete and anchored to the same initial presentation before endoscopy or intervention; measurement, unit, source-value, timing, and category identities must be verified, and the comorbidity category must not be inferred. This arithmetic does not establish the bleeding diagnosis, source-population applicability, or any clinical action.
- Limites et exclusions
- The complete or post-endoscopy Rockall score, endoscopic diagnosis, endoscopic stigmata of recent hemorrhage, or any attempt to derive or imply those missing components. · Any published or later threshold, low/high or other result category, individual probability or estimate of mortality, rebleeding, intervention, surgery, transfusion, or length of stay, prognosis, reassurance, disposition, admission, discharge or outpatient-care decision, endoscopy timing, monitoring, management, treatment, recommendation, or any other clinical decision. · Age 16 years or younger; no independently established suspected acute upper-gastrointestinal hemorrhage; lower-GI or nonacute bleeding; use outside the original UK source setting without independent transportability assessment; a post-endoscopy assessment; or values from different presentations, episodes, time points, or after intervention. · Missing, inferred, imputed, default-normal, carried-forward, rounded-before-scoring, nonquantitative, or otherwise unverified inputs; an unknown comorbidity treated as none; automatic inference of a source comorbidity category; an altered category; or a partial score.
Origine de l’outil PharmaTek
Outil importé de la bibliothèque PharmaTek de MDose. Aucune date de révision clinique indépendante n’est documentée dans cette version.
- Bibliothèque source
- PharmaTek · MDose
- Version importée
- 4b66536936ed
- État de publication
- Révision clinique en cours
POURSUIVRE AVEC MDOSE
Un outil. Un premier lien.
Recevez des nouvelles des outils ou discutez d’une collaboration. L’utilisation de PharmaTek reste accessible sans laisser vos coordonnées.
Médecins et partenaires